论文部分内容阅读
WHO“造血系统肿瘤和淋巴组织肿瘤病理学分类”将淋巴组织肿瘤分为B细胞肿瘤、T细胞和NK细胞肿瘤及霍奇金淋巴瘤3大类,又将NK细胞肿瘤分为NK母细胞瘤、结外NK/T细胞淋巴瘤(鼻型)以及侵袭性NK细胞白血病。NK细胞肿瘤有明显的异质性,无论是生物学行为、预后,还是对治疗的反应方面都具有特殊性。NK细胞肿瘤侵袭性高,极易产生耐药性,预后差,生存时间短,目前尚无最佳的治疗模式。为帮助人们加深对这一疾病的认识,本文介绍NK细胞肿瘤的临床病理学研究现状。
WHO “Hematopoietic system of tumor and lymphoid tissue pathology classification ” will be divided into lymphoid tumor B cell tumor, T cell and NK cell tumor and Hodgkin’s lymphoma three categories, in turn NK cell tumor is divided into NK mother Cell tumor, extranodal NK / T cell lymphoma (nasal type), and aggressive NK cell leukemia. NK cell tumors have obvious heterogeneity, whether it is biological behavior, prognosis, or the response to treatment has particularity. NK cell tumor is highly invasive, prone to drug resistance, poor prognosis, short survival time, there is no optimal treatment model. To help people to deepen their understanding of the disease, this article describes the clinical pathology of NK cell tumors.